Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home News

2026 deadlines loom as Congress leaves DC with several unfinished battles

admin by admin
December 26, 2025
in News
0
2026 deadlines loom as Congress leaves DC with several unfinished battles
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Capitol Hill is a ghost town with both the House and Senate out of session until a few days into the new year.

Lawmakers left town the week before Christmas, and with their departure have left several key fights unresolved — with deadlines looming large for both Republicans and Democrats.

Government funding

Congress voted to end the longest-ever government shutdown in history last month after 43 days of gridlock.

But lawmakers did not strike a deal on federal funding for the rest of fiscal year (FY) 2026, which they’re expected to do annually. Instead, they passed a portion of FY 2026 funding while punting the deadline for the majority of areas to Jan. 30.

Senate Republicans had hoped to strike a deal on the vast majority of the remaining funds before leaving town, but various objections from senators on both sides of the aisle delayed an actual vote. 

Now, that legislation will have to be reckoned with in early January. During that month, the House and Senate will only have a total of eight days in session together before the Jan. 30 deadline.

The Senate will have 15 total days in session, while the House will have 12.

Healthcare

Millions of people across the country are expected to see an increase in how much they pay for healthcare premiums every month starting in January.

Congress, meanwhile, has failed to pass a compromise between the House and Senate to help Americans deal with the rising cost.

For some Americans on Obamacare, part of that is due to COVID-19 pandemic-era enhanced subsidies expiring at the end of 2025. 

Republicans have largely rejected the notion of extending those subsidies, at least without significant reforms. But a small group of moderate GOP lawmakers are pushing for a short-term extension to give Congress time to create a more permanent system for lowering costs.

The House passed a healthcare reform bill aimed at expanding options in the commercial insurance marketplace the week before leaving town. In the Senate, however, dueling plans by Republicans and Democrats failed to advance.

It will now be an issue for GOP congressional leaders to tackle in 2026 — while Democrats are likely to seize on it as an election-year issue.

Redistricting

Mid-decade redistricting has upended state and federal politics across the U.S. this year, with President Donald Trump pushing multiple GOP-controlled states to change their congressional lines in order to give Republicans an advantage in the 2026 midterms.

Democrat-led states like California have responded by moving to redraw their own maps to give the left an advantage. It’s resulted in prolonged court battles on both sides.

In Texas, where new maps could give Republicans as many as five new House seats, the Supreme Court granted an emergency stay on a lower court’s order allowing the GOP-led initiative to move forward.

The federal court battle over the Golden State’s new map is likely to draw into the new year. Meanwhile, states like Virginia, Illinois, Alabama, and Louisiana could still move to make new lines before next November.

Multiple House lawmakers have introduced legislation to ban mid-decade redistricting, but to no avail so far.

House Minority Leader Hakeem Jeffries, D-N.Y., warned at a press conference earlier this month, ‘Republicans may have started this redistricting battle. We as Democrats plan to finish it.’

Speaker Mike Johnson, R-La., by contrast, has taken a largely hands-off approach, preferring to leave the matter to state legislatures and the courts.

This post appeared first on FOX NEWS

Previous Post

Israel FM accuses Palestinian Authority of aiding terror with ‘Pay-for-Slay’ after deadly attack

Next Post

Herbalife stock price rebounded in 2025: will the rally continue?

Next Post
Herbalife stock price rebounded in 2025: will the rally continue?

Herbalife stock price rebounded in 2025: will the rally continue?

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

February 19, 2025
Nike stock: does Tim Cook’s purchase make NKE a buy at current valuations?

Nike stock: does Tim Cook’s purchase make NKE a buy at current valuations?

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

0
Nike stock: does Tim Cook’s purchase make NKE a buy at current valuations?

Nike stock: does Tim Cook’s purchase make NKE a buy at current valuations?

December 26, 2025
Nvidia to buy AI chip startup Groq in $20 billion blockbuster deal

Nvidia to buy AI chip startup Groq in $20 billion blockbuster deal

December 26, 2025
Looking back at 2025: the year embedded finance eroded traditional banks’ moat

Looking back at 2025: the year embedded finance eroded traditional banks’ moat

December 26, 2025
DAX Index’s best and worst performers in 2025

DAX Index’s best and worst performers in 2025

December 26, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Nike stock: does Tim Cook’s purchase make NKE a buy at current valuations?

    Nike stock: does Tim Cook’s purchase make NKE a buy at current valuations?

    December 26, 2025
    Nvidia to buy AI chip startup Groq in $20 billion blockbuster deal

    Nvidia to buy AI chip startup Groq in $20 billion blockbuster deal

    December 26, 2025
    Looking back at 2025: the year embedded finance eroded traditional banks’ moat

    Looking back at 2025: the year embedded finance eroded traditional banks’ moat

    December 26, 2025
    DAX Index’s best and worst performers in 2025

    DAX Index’s best and worst performers in 2025

    December 26, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved